ArticleInternational journal of oncology2021

Metformin impairs cisplatin resistance effects in A549 lung cancer cells through mTOR signaling and other metabolic pathways.

Ana Paula Morelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.